CV Sciences, Inc

(OTCQB:CVSI)

Latest On CV Sciences, Inc (CVSI):

Date/Time Type Description Signal Details
2023-05-15 20:05 ESTNewsCV Sciences Non-GAAP EPS of $0.00, revenue of $4.15MN/A
2023-05-15 20:05 ESTNewsCV Sciences, Inc. (CVSI) Q1 2023 Earnings Call TranscriptN/A
2023-03-30 00:00 ESTNewsCV Sciences Non-GAAP EPS of -$0.05, revenue of $16.2MN/A
2023-03-30 00:00 ESTNewsCV Sciences, Inc. (CVSI) Q4 2022 Earnings Call TranscriptN/A
2022-11-14 21:35 ESTNewsCV Sciences Non-GAAP EPS of -$0.01, revenue of $3.75MN/A
2022-11-14 21:35 ESTNewsCV Sciences, Inc. (CVSI) Q3 2022 Earnings Call TranscriptN/A
2022-11-12 00:10 ESTNewsCV Sciences Q3 Earnings PreviewN/A
2022-08-26 00:21 ESTNewsCV Sciences extinguishes convertible debtN/A
2022-08-16 03:29 ESTNewsCV Sciences Q2 revenue falls 19% Y/Y while strategic review continuesN/A
2022-08-16 03:29 ESTNewsCV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-15 09:59 ESTNewsCV Sciences Non-GAAP EPS of -$0.02 beats by $0.01, revenue of $4.1M misses by $0.78MN/A
2022-05-17 02:28 ESTNewsCV Sciences GAAP EPS of -$0.02 beats by $0.01, revenue of $4.45M misses by $0.39MN/A
2022-05-17 02:28 ESTNewsCV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-14 09:41 ESTNewsCV Sciences Q1 2022 Earnings PreviewN/A
2022-04-01 01:46 ESTNewsCV Sciences Non-GAAP EPS of -$0.10, revenue of $20.05MN/A
2022-01-05 16:17 ESTNewsCV Sciences signs distribution deal with GNCN/A
2021-11-15 19:36 ESTNewsCV Sciences EPS beats by $0.03, misses on revenueN/A
2021-11-15 19:35 ESTNewsCV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-15 19:35 ESTNewsCV Sciences +11% on announcing convertible note financingN/A
2021-10-08 02:21 ESTNewsCV Sciences surges as California passes law permitting retail sales of products containing CBDN/A
2021-08-14 04:10 ESTNewsCantor highlights reasons to be optimistic on CBD stocksN/A
2021-08-13 07:49 ESTNewsCV Sciences EPS misses by $0.01, beats on revenueN/A
2021-08-13 07:49 ESTNewsCV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-22 17:54 ESTNewsCV Sciences CEO Joseph Dowling - Mainstreaming Cannabinoids (Video)N/A
2021-04-14 02:43 ESTNewsCV Sciences and Alkemist Labs team up in Cannabis quality assurance programN/A
2021-03-19 10:22 ESTNewsCV Sciences EPS beats by $0.01, misses on revenueN/A
2021-03-19 10:21 ESTNewsCV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-19 01:11 ESTEarnings EstimateAn EPS average of $0.01 is estimated for the 2022 year.Buy
2021-03-19 01:11 ESTEarnings EstimateAn EPS average of -$0.01 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-19 01:11 ESTAnalyst RatingThe Analyst Target Price has decreased from $0.92 to $0.82.Neutral
2021-01-29 12:43 ESTNewsCV Sciences cut at Cantor Fitzgerald with profitability seen as still far offN/A
2021-01-15 21:01 ESTNewsCV Sciences (CVSI) Investor Presentation - SlideshowN/A
2020-12-08 19:11 ESTNewsCV Sciences inks stock purchase agreement with Tumim Stone CapitalN/A
2020-12-04 06:42 ESTFinancialsCompany financials have been released.Neutral
2020-12-03 18:16 ESTNewsCV Sciences: CBD Is All The Rage Yet This Stock Will Get RavagedN/A
2020-11-28 13:07 ESTNewsStocks To Watch: Spotlight On OPEC, Nikola And FordN/A
2020-11-27 01:13 ESTFinancialsCompany financials have been released.Neutral
2020-11-21 13:07 ESTNewsStocks To Watch: Eyes On Best Buy, Vaccines And Holiday CheerN/A
2020-11-09 07:22 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 07:22 ESTEarnings EstimateAn EPS average of -$0.01 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-09 07:22 ESTAnalyst RatingThe Analyst Target Price has decreased from $0.93 to $0.92.Neutral
2020-11-08 00:47 ESTNewsCV Sciences Inc's (CVSI) CEO Joe Dowling on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-06 00:59 ESTNewsCV Sciences EPS misses by $0.01, misses on revenueN/A
2020-10-08 21:35 ESTFinancialsCompany financials have been released.Neutral
2020-10-04 15:50 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 16:54 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 09:33 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 12:59 ESTFinancialsCompany financials have been released.Neutral
2020-08-10 07:52 ESTAnalyst RatingThe Analyst Target Price has increased from $0.89 to $0.93.Buy
2020-08-09 03:37 ESTFinancialsCompany financials have been released.Neutral

About CV Sciences, Inc (CVSI):

CV Sciences, Inc. operates as a life science company. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets hemp-based cannabidiol (CBD) products under the name of PlusCBD in a range of market sectors, including nutraceutical, beauty care, and specialty foods. It serves internet sales, direct-to-consumer health and wellness stores, collectives, cooperatives, master distributors, specialty retailers, and convenience stores, as well as food, drug, and mass merchandise retailers. The Specialty Pharmaceutical segment focuses on developing and commercializing cannabinoids to treat medical indications. Its products product candidates are based on proprietary formulations, processes, and technology. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.

CVSI Quotes by TradingView

See Advanced Chart

General

  • Name CV Sciences, Inc
  • Symbol CVSI
  • Type Common Stock
  • Exchange OTCQB
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 118
  • Fiscal Year EndDecember
  • Gic SectorConsumer Staples
  • Gic GroupHousehold & Personal Products
  • Gic IndustryPersonal Products
  • Gic SubIndustryPersonal Products
  • Web URLhttp://www.cvsciences.com
View More

Valuation

  • Forward PE 15.63
  • Price/Sales (Trailing 12 Mt.) 2.11
  • Price/Book (Most Recent Quarter) 3.11
  • Enterprise Value Revenue 2.18
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Current Year EPS Estimate -$0.04
  • Next Year EPS Estimate $0.01
  • Next Quarter EPS Estimate -$0.02
  • Profit Margin -69%
  • Operating Margin -60%
  • Return on Assets -23%
  • Return on Equity -75%
  • Revenue 28.56 million
  • Earnings Per Share -$0.02
  • Revenue Per Share $0.29
  • Gross Profit 35.09 million
  • Quarterly Earnings Growth -55.9%
View More

Highlights

  • Market Capitalization 60.48 million
  • EBITDA 1.34 million
  • Analyst Target Price $0.82
  • Book Value Per Share $0.19
View More

Share Statistics

  • Shares Outstanding 100.02 million
  • Shares Float 94.3 million
  • % Held by Insiders 595%
  • % Held by Institutions 0.01%
View More

Technicals

  • Beta 0.95
  • 52 Week High $1.27
  • 52 Week Low $0.35
  • 50 Day Moving Average 0.68
  • 200 Day Moving Average 0.56
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

CV Sciences, Inc (CVSI) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

CV Sciences, Inc (CVSI) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312020-12-31-$0.09-$0.02-350%
2020-09-302020-11-05$N/A-$0.03-$0.02-50%
2020-06-302020-08-06$N/A-$0.05-$0.03-78.57%
2020-03-312020-05-08$8.27 million-$0.05-$0.04-25%
2019-12-312020-03-16$9.33 million-$0.07-$0.01-833.33%
2019-09-302019-11-05$12.6 million-$0.02$0.01-398.51%
2019-06-302019-08-06$16.85 million$0.01$0.03-60%
2019-03-312019-05-08$14.91 million-$0.10$0.02-600%
2018-12-312019-03-12$14.22 million$0.03$0.0250%
2018-09-302018-11-07$13.6 million$0.03$0.0250%
2018-06-302018-08-01$12.35 million$0.03
2018-03-312018-05-14$8.07 million$0.01
2017-12-312018-03-30$7.24 million$0.01
2017-09-302017-11-08$5.59 million-$0.01
2017-06-302017-06-30$4.08 million-$0.01
2017-03-312017-03-31$3.76 million-$0.06
2016-12-312016-12-31$3.21 million-$0.15
2016-09-302016-09-30$2.94 million-$0.04
2016-06-302016-06-30$2.49 million-$0.04
2016-03-312016-03-31$2.42 million-$0.03
2015-12-312015-12-31$2.25 million-$0.15
2015-09-302015-09-30$4.15 million-$0.03
2015-06-302015-06-30$2.41 million-$0.06
2015-03-312015-03-31$2.71 million-$0.08
2014-12-312014-12-31$2.69 million-$0.26
2014-09-302014-09-30$1.86 million-$0.01
2014-06-302014-06-30$3.01 million$0.24
2014-03-312014-03-31$2.63 million$-0.00
2013-12-312013-12-31$800000$2.98
2013-09-302013-09-30$164000-$2.81
2013-06-302013-06-30$108000-$0.12
2013-03-312013-03-31$1.08 million$0.05
2012-12-312012-12-31$N/A$-0.00
2012-09-302012-09-30$N/A$-0.00
2012-06-302012-06-30$N/A$-0.00
2012-03-312012-03-31$N/A$-0.00
2011-12-312011-12-31$-0.00

CV Sciences, Inc (CVSI) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

CV Sciences, Inc (CVSI) Chart:

CV Sciences, Inc (CVSI) News:

Below you will find a list of latest news for CV Sciences, Inc (CVSI) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

CV Sciences, Inc (CVSI) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

CV Sciences, Inc (CVSI) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000060/0001510964-20-000060-index.htm
2020-04-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1510964/000000000020003538/0000000000-20-003538-index.htm
2019-10-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096419000059/0001510964-19-000059-index.htm
2019-11-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096419000061/0001510964-19-000061-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1510964/000151096419000064/0001510964-19-000064-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1510964/000151096419000066/0001510964-19-000066-index.htm
2019-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096419000068/0001510964-19-000068-index.htm
2019-11-088-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1510964/000151096419000070/0001510964-19-000070-index.htm
2019-11-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096419000074/0001510964-19-000074-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1510964/000151096419000076/0001510964-19-000076-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096419000079/0001510964-19-000079-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096419000082/0001510964-19-000082-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000002/0001510964-20-000002-index.htm
2020-02-125Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000004/0001510964-20-000004-index.htm
2020-03-16NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1510964/000151096420000009/0001510964-20-000009-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000010/0001510964-20-000010-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000012/0001510964-20-000012-index.htm
2020-03-20PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000014/0001510964-20-000014-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000016/0001510964-20-000016-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000018/0001510964-20-000018-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000020/0001510964-20-000020-index.htm
2020-03-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000022/0001510964-20-000022-index.htm
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1510964/000151096420000026/0001510964-20-000026-index.htm
2020-03-31DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000029/0001510964-20-000029-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000031/0001510964-20-000031-index.htm
2020-04-21S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1510964/000151096420000034/0001510964-20-000034-index.htm
2020-04-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000037/0001510964-20-000037-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000039/0001510964-20-000039-index.htm
2020-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1510964/000151096420000041/0001510964-20-000041-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000043/0001510964-20-000043-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000045/0001510964-20-000045-index.htm
2020-06-02DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000047/0001510964-20-000047-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000050/0001510964-20-000050-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000052/0001510964-20-000052-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000054/0001510964-20-000054-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000056/0001510964-20-000056-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000058/0001510964-20-000058-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000060/0001510964-20-000060-index.htm
2020-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000062/0001510964-20-000062-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000064/0001510964-20-000064-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1510964/000151096420000067/0001510964-20-000067-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1510964/000151096420000072/0001510964-20-000072-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1510964/000151096420000077/0001510964-20-000077-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000157279520000003/0001572795-20-000003-index.htm
2020-08-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1510964/000157279520000004/0001572795-20-000004-index.htm
2020-04-30EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1510964/999999999520000937/9999999995-20-000937-index.htm

CV Sciences, Inc (CVSI) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of CV Sciences, Inc (CVSI). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 595%
Institutional Ownership: 1%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-12-27Michael III MonaChief Operating OfficerBuy250,000.000.40100,000.001,230,000.00https://www.sec.gov/Archives/edgar/data/1510964/000151096419000082/0001510964-19-000082-index.htm
2020-05-14PAUL BLAKEDirectorBuy12,801.000.394,992.3912,801.00https://www.sec.gov/Archives/edgar/data/1510964/000151096420000043/0001510964-20-000043-index.htm
2019-11-07Joerg GrasserCFOBuy15,000.001.4922,288.5015,000.00https://www.sec.gov/Archives/edgar/data/1510964/000151096419000068/0001510964-19-000068-index.htm
2019-11-08Joseph D DowlingCEOBuy15,000.001.6524,750.0015,000.00https://www.sec.gov/Archives/edgar/data/1510964/000151096419000074/0001510964-19-000074-index.htm
2020-07-30Michael Joseph Jr Mona10% Share HolderSell58,535.000.5833,956.15174,662.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000004/0001572795-20-000004-index.htm
2020-07-29Michael Joseph Jr Mona10% Share HolderSell50,000.000.5829,170.00233,197.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000004/0001572795-20-000004-index.htm
2020-05-05Michael Joseph Jr Mona10% Share HolderSell136,285.000.4764,162.982,679,000.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-05-04Michael Joseph Jr Mona10% Share HolderSell109,239.000.4852,063.312,815,285.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-06-10Michael Joseph Jr Mona10% Share HolderSell8,803.000.807,042.40283,197.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000003/0001572795-20-000003-index.htm
2020-05-22Michael Joseph Jr Mona10% Share HolderSell30,000.000.8024,000.00292,000.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000003/0001572795-20-000003-index.htm
2020-05-01Michael Joseph Jr Mona10% Share HolderSell42,790.000.4820,684.692,924,524.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-04-30Michael Joseph Jr Mona10% Share HolderSell16,840.000.518,655.762,967,314.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-04-29Michael Joseph Jr Mona10% Share HolderSell84,575.000.5344,968.532,984,154.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-04-28Michael Joseph Jr Mona10% Share HolderSell5,650.000.543,073.603,068,729.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-04-27Michael Joseph Jr Mona10% Share HolderSell207,226.000.52107,944.023,074,379.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-03-26Michael Joseph Jr Mona10% Share HolderSell25,000.000.7017,500.00322,000.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-04-23Michael Joseph Jr Mona10% Share HolderSell42,774.000.5121,998.673,281,605.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-04-22Michael Joseph Jr Mona10% Share HolderSell278,421.000.50139,683.823,324,379.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-02-14Michael Joseph Jr Mona10% Share HolderSell45,000.000.9542,750.00347,000.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-04-21Michael Joseph Jr Mona10% Share HolderSell77,200.000.5240,483.683,602,800.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-02-11Michael Joseph Jr Mona10% Share HolderSell8,000.000.957,600.00392,000.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-01-20Michael Joseph Jr Mona10% Share HolderSell80,000.001.2096,000.00400,000.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-01-15Michael Joseph Jr Mona10% Share HolderSell50,000.001.2060,000.00480,000.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-01-14Michael Joseph Jr Mona10% Share HolderSell50,000.001.1557,500.00530,000.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-01-14Michael Joseph Jr Mona10% Share HolderSell50,000.001.0552,500.00580,000.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-01-09Michael Joseph Jr Mona10% Share HolderSell25,000.001.0125,260.00630,000.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-01-09Michael Joseph Jr Mona10% Share HolderSell12,500.001.0212,750.00655,000.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-01-09Michael Joseph Jr Mona10% Share HolderSell12,500.001.0212,750.00667,500.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2019-12-05JOSEPH C MD MAROONDirectorBuy25,000.000.9824,500.00668,391.00https://www.sec.gov/Archives/edgar/data/1510964/000151096419000079/0001510964-19-000079-index.htm
2020-01-09Michael Joseph Jr Mona10% Share HolderSell25,221.001.0025,221.00680,000.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-01-08Michael Joseph Jr Mona10% Share HolderSell18,400.001.0018,400.00705,221.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2019-12-11JOSEPH C MD MAROONDirectorBuy46,725.001.0950,930.25715,116.00https://www.sec.gov/Archives/edgar/data/1510964/000151096419000079/0001510964-19-000079-index.htm
2020-01-07Michael Joseph Jr Mona10% Share HolderSell6,379.001.006,379.00723,621.00https://www.sec.gov/Archives/edgar/data/1510964/000157279520000002/0001572795-20-000002-index.htm
2020-02-06JOSEPH C MD MAROONDirectorBuy26,000.000.9424,440.00741,116.00https://www.sec.gov/Archives/edgar/data/1510964/000151096420000002/0001510964-20-000002-index.htm